Suppr超能文献

特发性正常压力脑积水(iNPH)的自然病史、治疗结果和生活质量。

Natural History, Treatment Outcomes and Quality of Life in Idiopathic Normal Pressure Hydrocephalus (iNPH).

机构信息

Division of Neurosurgery; Calgary Adult Hydrocephalus Program, University of Calgary, Calgary, Alberta, Canada.

Division of Neurosurgery; Calgary Adult Hydrocephalus Program; Department of Clinical Neuroscience, University of Calgary, Calgary, Alberta, Canada.

出版信息

Neurol India. 2021 Nov-Dec;69(Supplement):S561-S568. doi: 10.4103/0028-3886.332281.

Abstract

BACKGROUND

The natural history and treatment outcomes in adult patients with hydrocephalus is a broad and heterogeneous topic that encompasses the natural history of the various subtypes of adult hydrocephalus with or without treatment; their surgical operative results, including symptom improvements, treatment failure, short- and long-term complications, and reoperations; and morbidity, mortality, and patient-centered health-related quality of life (HRQoL).

OBJECTIVE, METHODS, AND MATERIALS: The objective of this review is to present a current update on the natural history and treatment outcomes, including QoL, for adults with hydrocephalus with a focus on patients with idiopathic normal pressure hydrocephalus (iNPH). A nonsystematic review of relevant literature was summarized.

RESULTS AND CONCLUSIONS

The natural history for untreated patients with iNPH is poor, with both increased mortality and morbidity. It is strongly recommended that practitioners follow established guidelines to select patients with suspected iNPH while using objective measures of gait, balance, and cognition for consideration of treatment with a CSF shunt. Other factors such as patient-related medical comorbidities or frailty may need to be factored into the decision-making process before surgical treatment is offered. As a rule, failure to select patients based on the identified guidelines will result in a significantly lower positive response to treatment with a CSF shunt. Over 90% of iNPH patients who undergo CSF-shunt treatment demonstrate symptomatic relief after surgery, and long-term studies have shown that in most patients, the clinical improvements are long-lasting, with over 70% demonstrating improvement longer than 6 years after treatment. There is no evidence to support the routine use of endoscopic third ventriculostomy (ETV) to treat patients with iNPH. There is limited data regarding HRQoL in patients with iNPH. In addition to objective measures of outcomes focused on gait and cognition, it is equally important for future studies to assess patient-centered subjective measures of HRQoL.

摘要

背景

成人脑积水的自然史和治疗结果是一个广泛而多样化的话题,涵盖了各种成人脑积水亚型(有或无治疗)的自然史;他们的手术结果,包括症状改善、治疗失败、短期和长期并发症以及再次手术;以及发病率、死亡率和以患者为中心的健康相关生活质量(HRQoL)。

目的、方法和材料:本综述的目的是介绍成人脑积水的自然史和治疗结果(包括 QoL)的最新情况,重点关注特发性正常压力脑积水(iNPH)患者。对相关文献进行了非系统性综述。

结果和结论

未经治疗的 iNPH 患者的自然史较差,死亡率和发病率均增加。强烈建议临床医生遵循既定指南选择疑似 iNPH 的患者,同时使用步态、平衡和认知的客观测量值来考虑使用 CSF 分流器进行治疗。其他因素,如患者相关的合并症或虚弱,可能需要纳入手术治疗前的决策过程。作为一项规则,如果不根据确定的指南选择患者,CSF 分流器治疗的阳性反应率将显著降低。超过 90%的接受 CSF 分流器治疗的 iNPH 患者在手术后表现出症状缓解,长期研究表明,在大多数患者中,临床改善是持久的,超过 70%的患者在治疗后 6 年以上仍有改善。没有证据支持常规使用内镜第三脑室造口术(ETV)治疗 iNPH 患者。关于 iNPH 患者的 HRQoL 数据有限。除了关注步态和认知的客观结局测量外,未来的研究同样重要的是评估以患者为中心的 HRQoL 主观测量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验